CHANGES IN CYTOKINES PROFILE OF THE RAT BLOOD SERUM FOLLOWING BRONCHOPULMONARY INFLAMMATION AND ADMINISTRATION OF IMMUNE MODULATORS
Abstract
The experimental bronchopneumonia was modeled in rats by administration of turpentine into the trachea under ether anesthesia. One of the immune modulators (polyoxydonium 0.75 mg/kg, trekrezan 25 mg/kg or metaprot 25 mg/kg) was injected intraperitoneally for 5 days (once a day) after operation. The rats were decapitated on 5th day and a profile of cytokines in the blood serum was determined using Milliplex Map Rat Citokine/Chemokine (Merk Millipore) sets. Inflammation decreased blood levels of both pro-inflammatory factors (IL-1β, IL-2, IL-12, interferon-γ and chemokine МСР-1) and anti-inflammatory cytokines (IL-4, IL-10). The content of TNFα and IL-6 and anti-inflammatory cytokine IL-13 was increased. Administration of immune modulators polyoxydonium, trekrezan and metaprot normalized the level of both pro-inflammatory (IL-1β, IL-2, IL-12(р7), chemokine МСР-1, interferon- γ) and anti-inflammatory (IL-4, IL-10) cytokines in significant degree. Therefore, anti-inflammatory effect of the drugs studied in connected with normalization of cytokine metabolism.
References
2. Зарубина И.В., Мокренко Е.В., Болехан А.В., Шабанов П.Д. Сравнительная противовоспалительная и эрготропная активность метапрота, трекрезана и полиоксидония и их комбинаций при экспериментальном бронхолегочном воспалении у крыс // Медицинский академический журнал. 2016. Т.16. №3. С. 48-50.
3. Коненков В.И., Макарова О.П., Бгатова Н.П., Ракова И.Г. Динамика изменения активности цитокинов и функций нейтрофилов в крови крыс после термического ожога кожи // Цитокины и воспаление. 2007. Т. 6. № 3. С. 57-62.
4. Михайленко А.А., Коненков В.И., Базанов Г.А., Покровский В.И. Руководство по клинической иммунологии, аллергологии, иммуногенетике и иммунофармакологии. М.: Триада, 2005. T.2. 1072 с.
5. Останин А.А., Леплина О.Ю., Шевела Е.Я. и др. Оценка цитокинового профиля у больных с тяжелым сепсисом методом проточной флюрометрии (Bio-Plex-анализа) // Цитокины и воспаление. 2004. Т.1. №3. С. 20-27.
6. Петров Р.В., Некрасов А.В., Аттаулаханов Р.И. и др. Полиоксидоний: механизм действия и клиническое применение // Медицинская иммунология. 2000. Т. 2. №3. С. 271-278.
7. Симбирцев А.С. Цитокины: новая система защитных реакций организма // Цитокины и воспаление. 2004. Т.1. №2. С. 16-22.
8. Шабанов П.Д., Зарубина И.В., Мокренко Е.В. Фармакология трекрезана – нового иммуномодулятора и адаптогена // Обзоры по клинической фармакологии и лекарственной терапии. 2014. Т. 12. №2. С. 12-27.
9. Homa H., Funtasu H., Yamasaki M. Pathogenesis of mascular edema with branch retinal vein occlusion and intraocular levels of vascular endothelial growth factor and interleukin-6 // Amer. J. Ophthalmol. 2005. Vol. 140. P. 256-261.
10. Oppenheim I. Cytokine Reference / I. Oppenheim, M. Feldman, eds. London: Academic Press, 2000. 2015 p.
11. Wynn T.A. Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases // J. Clin. Invest. 2007. Vol.117. №3. P. 524-529.
12. Zhang L.I. Interleukin-10 and chronic liver disease // World J. Gastroenterology. 2006. Vol.12. №11. Р. 16-81.
REFERENCES
1. Berezhnaya N.M. Cytokine regulation at pathology: rapid development and inevitable questions // Citokiny i vospalenie. 2007. Vol. 2 (6). P. 26-34. (in Russian)
2. Zarubina I.V., Mokrenko E.V., Bolehan A.V., Shabanov P.D. Comparative anti-inflammatory and ergotropny activity metapro-that, a trekrezana and a polioksidoniya and their combinations at experimental bronchopulmonary inflammation at rats // Meditsinskij Akademicheskij Zhurnal. 2016. Vol. 16 (3). P. 48-50. (in Russian)
3. Konenkov V.I., Makarova O.P., Bgatova N.P., Rakova I.G. Dynamics of change of activity of Cytokine and functions of neutrophils in blood of rats after a thermal burn of skin // Citokiny i vospalenie. 2007. Vol.6 (3). P. 57-62. (in Russian)
4. Mihailenko A.A., Konenkov V.I., Bazanov G.A., Pokrovskii V.I. Guide to clinical immunology, allergology, immunogenetics and immunopharmacology. Moscow: Triada, 2005. Vol. 2. 1072 p. (in Russian)
5. Ostanin A.A., Leplina O.Yu., Shevela E.Ya., et al. Assessment of a Cytokine profile at patients with heavy sepsis by method of a flowing flyurometriya (Bio-Plex-analysis) // Citokiny i vospalenie. 2004. Vol.1 (3). P. 20-27. (in Russian)
6. Petrov R.V., Nekrasov A.V., Attaulahanov R.I., et al. Polyoxydoñas: mechanism of action and clinical application // Meditsinskaya immunologiya. 2000. Vol.2 (3). P. 271-278. (in Russian)
7. Simbircev A.S. Cytokine: new system of protective reactions of an organism // Citokiny i vospalenie. 2004. Vol. 1 (2. - V. 16-22. (in Russian)
8. Shabanov P.D., Zarubina I.V., Mokrenko E.V. Pharmacology of a trekrezan – a new immunomodulator and an adaptogen // Obzory po klinicheskoj farmakologii i lekarstvennoj terapii. 2014. Vol.12 (2). P. 12-27. (in Russian)
9. Homa H., Funtasu H., Yamasaki M. Pathogenesis of mascular edema with branch retinal vein occlusion and intraocular levels of vascular endothelial growth factor and interleukin-6 // Amer. J. Ophthalmol. 2005. Vol. 140. P. 256-261.
10. Oppenheim I. Cytokine Reference / I. Oppenheim, M. Feldman, eds. London: Academic Press, 2000. 2015 p.
11. Wynn T.A. Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases // J. Clin. Invest. 2007. Vol.117. N.3. P. 524-529.
12. Zhang L.I. Interleukin-10 and chronic liver disease // World J. Gastroenterology. 2006. Vol.12, N.11. Р. 16-81.

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.